In particular, MYCN represents one of the most important driver genes in neuroblastoma, being gene amplification strongly correlated to unfavorable outcome, although in vitro and in vivo data suggest that there is no direct correlation between a high cellular MYCN protein content and aggressive tumor cell behavior or loss of differentiation [5]. The gene discussed is MYCN; the disease is neoplasm.